Flurbiprofen-Loaded Solid SNEDDS Preconcentrate for the Enhanced Solubility, In-Vitro Dissolution and Bioavailability in Rats.

Rae Man Kim, Dong-Jin Jang, Yu Chul Kim, Jin-Ha Yoon, Kyoung Ah Min, Han-Joo Maeng, Kwan Hyung Cho
Author Information
  1. Rae Man Kim: College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea. didi032@naver.com.
  2. Dong-Jin Jang: Department of Pharmaceutical Engineering, Inje University, Gimhae 50834, Korea. djjang@inje.ac.kr.
  3. Yu Chul Kim: Department of Pharmaceutical Engineering, Inje University, Gimhae 50834, Korea. yckim@inje.ac.kr. ORCID
  4. Jin-Ha Yoon: College of Pharmacy, Gachon University, Incheon 21936, Korea. jinha89@daum.net.
  5. Kyoung Ah Min: College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea. minkahh@inje.ac.kr.
  6. Han-Joo Maeng: College of Pharmacy, Gachon University, Incheon 21936, Korea. hjmaeng@gachon.ac.kr.
  7. Kwan Hyung Cho: College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea. chokh@inje.ac.kr.

Abstract

The aim of this work was to prepare and optimize a solid self-nanoemulsifying drug delivery system pre-concentrate (SSP) containing water-insoluble flurbiprofen (FL) using a novel pseudo-ternary phase diagram. The pseudo-ternary phase diagram, composed of FL as the drug and dispersion core, Kollisolv MCT 70 as the oil phase, and TPGS (tocopherol polyethylene glycol 1000 succinate) as the surfactant, was constructed for the determination of the SSP region. SSP was investigated in terms of particle size, physical state by differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD), in vitro dissolution and oral pharmacokinetics in rats. The determined SSP (FL/Kollisolv MCT 70/TPGS = 10/10/80, weight %) in the pseudo-ternary phase diagram had the melting point of 32.37 °C and uniform mean particle size of below 30 nm without any precipitation of FL in the dispersion. In the dissolution test, the SSP exhibited 95.70 ± 3.40% of release at 15 min, whereas the raw FL showed poor dissolution (i.e., 6.75 ± 1.30%) at that time point. In addition, the SSP showed the enhanced oral absorption (i.e., 1.93-fold increase in AUC) as compared to the suspension group of raw FL. Therefore, the developed SSP would be a promising drug delivery system with excellent solubilization, dissolution, and bioavailability for FL.

Keywords

References

  1. Bioorg Med Chem Lett. 1999 Feb 8;9(3):307-12 [PMID: 10091674]
  2. Int J Pharm. 2003 Jan 30;251(1-2):79-84 [PMID: 12527177]
  3. Adv Colloid Interface Sci. 2004 May 20;108-109:303-18 [PMID: 15072948]
  4. Eur J Pharm Sci. 2006 Jun;28(3):233-42 [PMID: 16650738]
  5. Eur J Pharm Sci. 2006 Nov;29(3-4):278-87 [PMID: 16815001]
  6. AAPS PharmSciTech. 2008;9(2):628-34 [PMID: 18473177]
  7. AAPS PharmSciTech. 2009;10(3):906-16 [PMID: 19609837]
  8. Arch Pharm Res. 2010 Jan;33(1):95-101 [PMID: 20191350]
  9. Arch Pharm Res. 2010 Nov;33(11):1835-42 [PMID: 21116787]
  10. Eur J Pharm Biopharm. 2012 Feb;80(2):289-97 [PMID: 22119666]
  11. J Pharm Sci. 2013 Apr;102(4):1173-81 [PMID: 23362123]
  12. Drug Dev Ind Pharm. 2014 Apr;40(4):477-87 [PMID: 23465049]
  13. Pharm Res. 2013 Dec;30(12):2993-3017 [PMID: 23775443]
  14. Drug Deliv. 2015;22(6):675-90 [PMID: 24670091]
  15. Eur J Pharm Biopharm. 2015 Aug;94:64-72 [PMID: 25979136]
  16. Eur J Pharm Biopharm. 2016 Jul;104:164-70 [PMID: 27163245]
  17. Pharmaceutics. 2016 Jun 27;8(3):null [PMID: 27355963]
  18. Pak J Pharm Sci. 2017 Mar;30(2(Suppl.)):601-606 [PMID: 28650328]
  19. J Pharm Pharmacol. 2018 Jul;70(7):929-936 [PMID: 29607510]
  20. Eur J Pharm Sci. 2018 Sep 15;122:254-263 [PMID: 29981401]
  21. Eur J Pharm Biopharm. 2018 Sep;130:236-246 [PMID: 29981444]
  22. Molecules. 2018 Oct 11;23(10):null [PMID: 30314360]
  23. Clin Pharmacokinet. 1995 Feb;28(2):100-14 [PMID: 7736686]

Grants

  1. NRF-2018R1A2B6002686; 2016R1D1A1B03931470/Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)

Word Cloud

Created with Highcharts 10.0.0SSPFLdissolutiondrugphasedeliverysystempseudo-ternarydiagramsolidself-nanoemulsifyingflurbiprofendispersionMCT70particlesizeoralpoint±rawshowedie1bioavailabilityaimworkprepareoptimizepre-concentratecontainingwater-insolubleusingnovelcomposedcoreKollisolvoilTPGStocopherolpolyethyleneglycol1000succinatesurfactantconstructeddeterminationregioninvestigatedtermsphysicalstatedifferentialscanningcalorimetryDSCpowderX-raydiffractionPXRDvitropharmacokineticsratsdeterminedFL/Kollisolv70/TPGS=10/10/80weight%melting3237°Cuniformmean30nmwithoutprecipitationtestexhibited95340%release15minwhereaspoor67530%timeadditionenhancedabsorption93-foldincreaseAUCcomparedsuspensiongroupThereforedevelopedpromisingexcellentsolubilizationFlurbiprofen-LoadedSolidSNEDDSPreconcentrateEnhancedSolubilityIn-VitroDissolutionBioavailabilityRats

Similar Articles

Cited By (17)